|
1) Yu J, Auwerx J. The role of sirtuins in the control of metabolic homeostasis. Ann N Y Acad Sci. 2009; 1173 Suppl 1: E10-9
|
|
|
|
2) Chaudhary N, Pfluger PT. Metabolic benefits from Sirt1 and Sirt1 activators. Curr Opin Clin Nutr Metab Care. 2009; 12: 431-7
|
|
|
|
|
3) Kurosu H, Yamamoto M, Clark JD, et al. Suppression of aging in mice by the hormone Klotho. Science. 2005; 309: 1829-33
|
|
|
|
|
|
4) Imura A, Tsuji Y, Murata M, et al. alpha-Klotho as a regulator of calcium homeostasis. Science. 2007; 316: 1615-8
|
|
|
|
|
|
5) Ito K, Barnes PJ. COPD as a disease of acceler-ated lung aging. Chest. 2009; 135: 173-80
|
|
|
|
|
|
6) Sato T, Seyama K, Sato Y, et al. Senescence marker protein-30 protects mice lungs from oxidative stress, aging, and smoking. Am J Respir Crit Care Med. 2006; 174: 530-7
|
|
|
|
|
|
7) Mori T, Ishigami A, Seyama K, et al. Senescence marker protein-30 knockout mouse as a novel murine model of senile lung. Pathol Int. 2004; 54: 167-73
|
|
|
|
|
8) KuwanoK. Involvement of epithelial cell apoptosis in interstitial lung diseases. Intern Med. 2008; 47: 345-53
|
|
|
|
|
9) Kuwano K, Hagimoto N, Nakanishi Y. The role of apoptosis in pulmonary fibrosis. Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis. Histol Histopathol. 2004; 19: 867-81
|
|
|
|
|
|
10) Mitsudomi T, Hamajima N, Ogawa M, et al. Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis. Clin Cancer Res. 2000; 6: 4055-63
|
|
|
|
|
|
11) Tsuji T, Aoshiba K, Nagai A. Cigarette smoke induces senescence in alveolar epithelial cells. A role for the apoptosis inhibitory factor AIM/Spalpha/Api6 in atherosclerosis development. Am J Respir Cell Mol Biol. 2004; 31: 643-9
|
|
|
|
|
|
12) Arai S, Shelton JM, Chen M, et al. A role for the apoptosis inhibitory factor AIM/Spalpha/Api6 in atherosclerosis development. Cell Metab. 2005; 1: 201-13
|
|
|
|
|